Trial intelligence / Profile preview

TRULIGHT: Dual Therapy vs Triple Therapy in HIV Infected Patients

NCT02302547Phase 3Completed

Sponsor
University Hospital Tours
Start
Dec 2014
Primary completion
Aug 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by University Hospital Tours. Started Dec 2014; status: completed.

02

Drugs

emtricitabine + tenofovir disoproxil
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT02302547.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02302547.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call